TCL Archive Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says April 26, 1996
TCL Archive Rabson Recommended For NCI Acting Director, Will be Top Prospect For Permanent Appointment August 26, 1988
TCL Archive United Approach With Other Health Advocates Needed To Increase Cancer Dollars, Royboal Says February 10, 1978
TCL Archive Bipartisan Deal Eases Some Budget Cuts By Extending Sequestration Through 2023 December 13, 2013
TCL Archive NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification April 10, 1981
TCL Archive Bush Nominates von Eschenbach For FDA; Democrats Put Hold On Confirmation. von Eschenbach To Step Down As NCI Director, But Details Unavailable; No Acting Director Named. Applause, Outrage, Over Nomination. Now, von Eschenbach Leads A Retreat From 2015 Target Date For His Challenge Goal. March 17, 2006
